High-dose therapy and autologous haematopoietic stem-cell transplantation for HIV-1-associated lymphoma

Lancet. 2000 Mar 25;355(9209):1071-2. doi: 10.1016/S0140-6736(00)02041-9.

Abstract

We describe the results of autologous haematopoietic stem-cell transplantation in eight patients with HIV-1-associated lymphoma. Collection and grafting of stem cells is feasible and this treatment seems appropriate in chemotherapy-sensitive HIV-1-associated lymphoma.

Publication types

  • Letter

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Dose-Response Relationship, Drug
  • Female
  • HIV-1*
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Lymphoma, AIDS-Related / drug therapy*
  • Lymphoma, AIDS-Related / mortality
  • Male
  • Middle Aged
  • Survival Rate
  • Treatment Outcome